BusinessEarth Science Tech, Inc. Shares Achievements & Updates on it’s Cannabis CBD-Based Nutraceutical Patent CompoundingBy Nasdaq OMXMay 2, 2017, 11:45 AM UTC
BusinessETST Launches Cannabis Therapeutics Website, Shares Updates on their CBD-Based Nutraceutical Patents, & Hints on New Products Launching May 2017By Nasdaq OMXApr 20, 2017, 11:55 AM UTC
BusinessEarth Science Tech, Inc. Targets Breast Cancer and Other Women's Health Issues in New Cannabis CBD-Based Pharmaceutical Drug Development InitiativesBy Nasdaq OMXApr 11, 2017, 11:45 AM UTC
BusinessEarth Science Tech, Inc. Announces New Cannabis CBD-Based Sports Supplement with Forzagen, Karmavore Superfoods Sales Success, and Company UpdatesBy Nasdaq OMXMar 9, 2017, 12:35 PM UTC
BusinessETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.By Nasdaq OMXMar 6, 2017, 12:45 PM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
BusinessEarth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent StudiesBy Nasdaq OMXFeb 23, 2017, 11:45 AM UTC
